Saturday, August 9, 2025

Pure Extracts Outlines Psilocybin Study Timeline

Further details were released by Pure Extracts (CSE: PULL) this morning in relation to its study on the formulation and manufacturing of psilocybin-based active treatments for oral tablets, capsules and nasal gel. The company has now released the timetable as well as outlined the milestones for the study, which is expected to result in an investigational product.

News of the study was previously released by the company, with research to be conducted by company advisor Dr Alexander MacGregor at the Toronto Institute of Pharmaceutical Technology. The study itself is to focus on testing the rapid onset of psilocybin dosage forms that can be used for future efficacy trials, by both Pure and its customers.

It appears the entire product chain is to be included in the study, from formulating and manufacturing, to packaging and labelling. Also included is conformity and stability testing. Based on a 250-day timeline, the company has outlined the following key milestones:

  • Sourcing and procurement of medicinal ingredients, excipients & packaging materials
  • Raw Material Testing
  • Formulation and Manufacturing Process Development, Stability Testing
  • Clinical Batch Manufacturing
  • Quality Control Release Testing
  • Shipping of Clinical Batches to CRO

“We are excited about the R&D progress we are going to make with TIPT over the next 6 – 8 months while waiting to receive our Dealer’s License from Health Canada. We will be well prepared for our move into the controlled substances world of psychedelics and will have advanced knowledge regarding psilocybin and its associated novel delivery mechanisms.”

Ben Nikolaevsky, Pure Extracts CEO

Pure Extracts last traded at $0.62 on the CSE.


FULL DISCLOSURE: Pure Extracts is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Pure Extracts on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Gold/Silver: People Can Still Lose Money In This Bull Market!? | Rick Rule

He Said $300 Silver!? | Peter Krauth

Dollar Will Collapse, Gold and Silver Are the Only Safe Havens | Jim Rogers

Recommended

Nova Scotia Bans Forest Access to Prevent Wildfires

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Related News

Pure Extracts Announces Step Into Functional Mushroom Market

Pure Extracts (CSE: PULL) this morning released to the market its roadmap for the processing...

Thursday, November 26, 2020, 08:42:08 AM

Pure Extracts Enters LOI To Co-Develop CBD-Infused Functional Mushroom Products With Purica

Pure Extracts Technologies (CSE: PULL) has announced its first arrangement within the functional mushroom space...

Wednesday, December 9, 2020, 08:20:29 AM

Pure Extracts Enters Licensing Agreement For Fireball Cannabis Gummies

Pure Extracts (CSE: PULL) this morning announced its first licensing deal for its cannabis extracts...

Tuesday, February 16, 2021, 09:55:01 AM

Pure Extracts Sees First Commercial Sale Of CBD Oil

Pure Extracts (CSE: PULL) has completed its first commercial sale of CBD oil, and thereby...

Wednesday, February 10, 2021, 07:11:33 AM

Pure Extracts Scales Up THC, CBD Distillate Production

Pure Extracts (CSE: PULL) is looking to scale up its production of both THC and...

Tuesday, January 26, 2021, 07:01:18 AM